PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Inspire Medical Systems, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Inspire Medical Systems, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
  • Debt Due Cover Ratio: Debt due within a year is covered 54.2 times by its yearly operating cash. Higher than 95% of Healthcare companies in United States.

Where $100 of sales goes

$94Operating costs$0.0Interest$16Net profit

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$153

Over the last 3 years, every $100 of reported profit came with $153 of operating cash.

Higher than 52% of Healthcare companies in United States.

Self-Funding Ratio

2.7×

Over the last 3 years its own operating cash covered its investment spending (capex) 2.7 times.

Higher than 78% of Healthcare companies in United States.

Cash Locked Ratio

$25

For every $100 of sales, $25 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $11 tied up three years earlier.

More money tied up than 53% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

$38

Sales grew 124% in 3 years; of every extra $100 of sales, $38 became extra profit.

Higher than 62% of Healthcare companies in United States.

Asset Productivity Ratio

+124% / +61%

In 3 years sales changed by +124% while total assets changed by +61%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

54.2×

Debt due within a year is covered 54.2 times by its yearly operating cash.

Higher than 95% of Healthcare companies in United States.

Cash Cushion Ratio

+13%

Cash, after subtracting all debt, equals 13% of its market value (net cash).

Higher than 55% of Healthcare companies in United States.

Tangible Assets Ratio

—

Data incomplete

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

−1%

Share count fell 1% in 3 years (buybacks), so each share's slice of the company became larger.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Inspire Medical Systems, Inc. owes $0.11 for every $1 it owns. Net profit rose 172% in the year to Dec 2025.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

16.0

Investors pay $16.0 for every $1 of Inspire Medical Systems, Inc.'s yearly profit, lower than 71% of Healthcare companies in United States.

P/B ratio

2.54

The share price is 2.54 times Inspire Medical Systems, Inc.'s book value per share, lower than 51% of Healthcare companies in United States.

Market cap

$2.1 B

The total market value of all of Inspire Medical Systems, Inc.'s shares at today's price (share price × number of shares), larger than 76% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$826 M

What Inspire Medical Systems, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$28.56

Net worth divided by the number of shares. The share price of $72.66 is 2.5 times this, which is the P/B above.

Return on equity (ROE)

18.0%

Inspire Medical Systems, Inc. earned 18.0% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.

Owes vs Owns

0.11×

Inspire Medical Systems, Inc. owes $0.11 for every $1 it owns (low), lower than 85% of Healthcare companies in United States.

Dividend yield

None

Inspire Medical Systems, Inc. does not currently pay a dividend.

Revenue growth

+14%

Revenue rose 14% in the year to Dec 2025, and grew 31% a year on average over 3 years.

Profit growth

+172%

Net profit rose 172% in the year to Dec 2025.

Profit margin

15.9%

Inspire Medical Systems, Inc. keeps $16 of every $100 of revenue as net profit.

Cash quality

0.8×

Cash from Inspire Medical Systems, Inc.'s business was 0.8× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.

Interest cover

371.9×

Inspire Medical Systems, Inc.'s operating profit covered its interest costs 371.9 times in the year to Dec 2025.

Cash vs debt

Net cash

Inspire Medical Systems, Inc. held $276 M more cash than debt (net cash) at Dec 2025.

Questions

What is Inspire Medical Systems, Inc.'s P/E ratio?

Investors pay $16.0 for every $1 of Inspire Medical Systems, Inc.'s yearly profit, lower than 71% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Inspire Medical Systems, Inc.: $2.1 B ÷ $826 M (30 Jun 2026) = 2.5.

What is Inspire Medical Systems, Inc.'s return on equity?

Inspire Medical Systems, Inc. earned 18.0% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.

How much does Inspire Medical Systems, Inc. owe compared with what it owns?

Inspire Medical Systems, Inc. owes $0.11 for every $1 it owns (low), lower than 85% of Healthcare companies in United States.

Does Inspire Medical Systems, Inc. pay a dividend?

No. Inspire Medical Systems, Inc. does not currently pay a dividend.

Is Inspire Medical Systems, Inc.'s revenue growing?

Revenue rose 14% in the year to Dec 2025, and grew 31% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.